Medical Devices

FDA Approves Hydrogel Spacer to Curb Scarring After Uterine Adhesion Surgery

Juveena, a gel that sets inside the uterus and clears in two to three weeks, cut adhesion recurrence in a blinded trial. Key figures come from a subgroup and await publication.

Anam · Oct 21, 2026 · 8 min read

Sirolimus-Coated Balloon Beats Plain Angioplasty in First US Randomized Trial

SELUTION4SFA randomized 300 patients with narrowed leg arteries and met both its efficacy and safety endpoints, offering the field an alternative to paclitaxel.

Anam · Oct 18, 2026 · 7 min read

FDA Approves First Pulmonary Valve That Can Be Expanded as Children Grow

The AUTUS Size-Adjustable Valve uses synthetic ePTFE leaflets on a balloon-expandable frame that widens from 12.7 mm to 22 mm by catheter, aiming to cut repeat open-heart surgery in congenital heart disease.

Anam · Oct 17, 2026 · 8 min read

Search BiomedEdge

Medical Devices

FDA Approves Hydrogel Spacer to Curb Scarring After Uterine Adhesion Surgery

Sirolimus-Coated Balloon Beats Plain Angioplasty in First US Randomized Trial

FDA Approves First Pulmonary Valve That Can Be Expanded as Children Grow